A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2001
11/29/2001	WO2001090142A2 FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS
11/29/2001	WO2001090137A2 NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11β-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17β-METHOXY-ESTRA-4,9-DIEN-3-ONE
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090047A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	WO2001089558A2 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	WO2001089548A2 Pharmaceutical use of fibulin-1
11/29/2001	WO2001089543A2 Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
11/29/2001	WO2001089536A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/29/2001	WO2001089515A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/29/2001	WO2001089501A1 Polymerizable compositions and methods of use
11/29/2001	WO2001089497A2 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
11/29/2001	WO2001060835A8 Purine derivatives
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2000038666A3 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES
11/29/2001	US20010046956 May contain another compound to treat diabetes, sexual dysfunction, atherosclerosis, insulin resistance, impaired glucose tolerance, hypercholesterolemia or hypertriglyceridemia
11/29/2001	US20010046522 Herbal supplement for cognitive related impairment due to estrogen loss
11/29/2001	US20010046519 Compositions for nasal administration
11/29/2001	US20010046496 Administering to the human having a disease associated with leukocyte infiltration of mucosal tissues a humanized immunoglobulin or antigen-binding fragment having binidng specificity for alpha 4 beta 7 integrain
11/29/2001	DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists
11/29/2001	DE10024451A1 Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung Pharmaceutical form of administration for peptides, process for their preparation and use
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410593A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	CA2410567A1 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	CA2409592A1 Pharmceutical compositions comprising vip-related peptides for the treatment of sexual disorders
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2407028A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157996A1 New solid forms of mesoprogestin 11beta-(4E-(hydroxyiminomethyl)-phenyl)-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on
11/28/2001	EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives
11/28/2001	EP1157695A1 Method of treating obesity using a neurotensin receptor ligand
11/28/2001	EP1157694A1 Remedial agent for erectile dysfunction
11/28/2001	EP1157099A2 Substances for controlling fertility
11/28/2001	EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001	EP1156822A1 Treatment of infertility
11/28/2001	EP1156821A1 Treatment of infertility
11/28/2001	EP1156819A1 Methods and compositions for modulating fertility
11/28/2001	EP0853483A4 Novel peptides
11/28/2001	EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/28/2001	CN1324405A Novel G protein-coupled receptor proteins, DNAS thereof and ligands to the same
11/28/2001	CN1324241A Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
11/28/2001	CN1324238A Amelioration of apomorphine adverse effects
11/28/2001	CN1324233A Controlled-release pharmaceutical formulations contg. a CGMP PDE-5 inhibitor
11/28/2001	CN1323628A Kidney-invigorating and male sexual function improving traditional Chinese medicine prepn.
11/28/2001	CN1323627A Vaginitis treating traditional Chinese medicine prepn.
11/28/2001	CN1323626A Traditional Chinese medicine prepn. for raising male's sexual function
11/28/2001	CN1323623A Multipurpose medicine made of bamboo liquid and honey and its prepn.
11/28/2001	CN1075386C Method for producing Anruneixiao medicinal liquid
11/28/2001	CN1075375C Compounds with progesterone-antagonistic and anti-oestrogen properties intended from combined use in female contraception
11/27/2001	US6323242 Treatment of disorders secondary to organic impairments
11/27/2001	US6323241 Prostaglandin compositions and methods of treatment for male erectile dysfunction
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders.
11/27/2001	US6322493 Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
11/27/2001	CA2083286C Recombinant fibrinogenases, preparation and use thereof
11/25/2001	CA2309518A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088119A1 Novel g protein-coupled receptor protein and dna thereof
11/22/2001	WO2001088098A2 Fertilization of aged oocytes
11/22/2001	WO2001087882A2 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
11/22/2001	WO2001087881A1 Piperidyindoles as serotonin receptor ligands
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087810A1 Methods for the production of d-chiro-inositol and the use of d-chiro-inositol obtained therefrom
11/22/2001	WO2001087350A2 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	WO2001087343A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	WO2001087316A2 Composition and method for increasing testosterone levels
11/22/2001	WO2001087288A2 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/22/2001	WO2001087287A2 Use of pyrazole derivatives for treating infertility
11/22/2001	WO2001087267A1 Protein matrix materials, devices and methods of making and using thereof
11/22/2001	WO2001087265A2 Pharmaceutical form of administration for peptides, methods for its production and use
11/22/2001	WO2001087038A2 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE
11/22/2001	WO2001038355A3 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof
11/22/2001	WO2001037862A3 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
11/22/2001	WO2001015679A3 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders
11/22/2001	WO2000066165A8 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
11/22/2001	WO2000059542A9 Method for a programmed controlled ovarian stimulation protocol
11/22/2001	US20010044937 Transgenic intracytoplasmic sperm injection, retroviral gene transfer, intracytoplasmic nuclear injection, and pronuclear injection; useful as models for human disease/diagnosis, assessing safety and efficiency of drug and gene therapy
11/22/2001	US20010044544 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation
11/22/2001	US20010044474 Hydrogel-driven layered drug dosage form
11/22/2001	US20010044441 And female sexual dysfunction, premature labour or dysmenorrhea
11/22/2001	US20010044436 Bicyclic inhibitors of glycogen synthase kinase 3
11/22/2001	US20010044434 Treating timidity and enhancing libido in postmenopausal women, or treating male sexual dysfunction by administering to a patient in need thereof an effective amount of an estrogen agonist/antagonist
11/22/2001	US20010044429 Administering for 21 successive days to a female of childbearing age a combination of an estrogen and a progestogen in a contraceptively effective daily dosage
11/22/2001	CA2410091A1 Piperidyindoles as serotonin receptor ligands
11/22/2001	CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001	CA2408830A1 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2407469A1 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	CA2405507A1 Use of pyrazole derivatives for treating infertility
11/22/2001	CA2404822A1 Fertilization of aged oocytes
11/21/2001	EP1156111A1 Chimeric arterivirus-like particles
11/21/2001	EP1155014A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
11/21/2001	EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001	EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase

1 ... 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 ... 557